title: Tuberculous sepsis during antiviral HCV triple therapy.
authors.forename: Stephanie
authors.initials: S
authors.lastname: Hametner
authors.forename: Fabio
authors.initials: F
authors.lastname: Monticelli
authors.forename: Jan Marco
authors.initials: JM
authors.lastname: Kern
authors.forename: Rainer
authors.initials: R
authors.lastname: Schöfl
authors.forename: Alexander
authors.initials: A
authors.lastname: Ziachehabi
authors.forename: Andreas
authors.initials: A
authors.lastname: Maieron
mesh_terms: D000328:Adult; D000998:Antiviral Agents / Q000008:administration & dosage / Q000009:adverse effects*; D004359:Drug Therapy, Combination; D017809:Fatal Outcome; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects; D008297:Male; D012307:Risk Factors; D018805:Sepsis / Q000209:etiology*; D015819:Substance Abuse, Intravenous / Q000150:complications; D014397:Tuberculosis, Pulmonary / Q000209:etiology*
chemical_list: D000998:Antiviral Agents; D007166:Immunosuppressive Agents